Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.52 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9361312 | 1.00 | PTGES (0.55) | PTGESTP53TSHRCISD1KDM4E | |
| SCHEMBL9360606 | 1.00 | PTGES (0.55) | PTGESTP53TSHRCISD1KDM4E | |
| SCHEMBL29918400 | 1.00 | PTGES (0.55) | PTGESTP53TSHRCISD1KDM4E | |
| SCHEMBL9361056 | 0.99 | CISD1 (0.54) | PTGESCISD1KDM4ESLC16A3ALDH1A1 | |
| SCHEMBL9361052 | 0.99 | CISD1 (0.54) | PTGESCISD1KDM4ESLC16A3ALDH1A1 | |
| SCHEMBL9365514 | 0.96 | CISD1 (0.56) | CISD1KDM4ESLC16A3ALDH1A1CYP3A4 | |
| SCHEMBL9365521 | 0.96 | CISD1 (0.56) | CISD1KDM4ESLC16A3ALDH1A1CYP3A4 | |
| SCHEMBL12296669 | 0.93 | PTGES (0.52) | PTGESCISD1KDM4ESLC16A3ALDH1A1 | |
| SCHEMBL21572153 | 0.93 | PTGES (0.52) | PTGESCISD1KDM4ESLC16A3ALDH1A1 | |
| SCHEMBL21561423 | 0.93 | PTGES (0.52) | PTGESCISD1KDM4ESLC16A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-10-31 | — | — | US | claimed |
| US-20210198188-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2021-07-01 | — | — | US | claimed |
| WO-2020017739-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | 한국화학연구원 | 2020-01-23 | — | — | WO | claimed |
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-10-31 | — | — | US | disclosed |
| US-20210198188-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2021-07-01 | — | — | US | disclosed |
| WO-2020017739-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | 한국화학연구원 | 2020-01-23 | — | — | WO | disclosed |
| EP-0335641-B1 | Organic nonlinear optical substance | TEIJIN LTD (JP) | 1994-01-05 | — | — | EP | disclosed |
| US-5196147-A | Optical crystals | TEIJIN LIMITED (JP) | 1993-03-23 | — | — | US | disclosed |
| EP-0335641-A2 | Organic nonlinear optical substance | TEIJIN LIMITED (JP) | 1989-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | DCX, CDH1, CACNA2D3 | PTGES 4547/4885TP53 1973/4885TSHR 4282/4885 |
| US-20210198188-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | DCX, HCN3, CDH1 | PTGES 4608/4885TP53 1756/4885TSHR 4369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.